SODIUM THIOSULFATE
| Brand name | SODIUM THIOSULFATE |
|---|---|
| Active ingredient | SODIUM THIOSULFATE |
| Strength | 12.5GM/50ML (250MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | February 2012 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8496973 | March 2031 | substance, product |
| 9345724 | July 2030 | substance, product |
| 10479686 | July 2030 | product |
| 9585912 | July 2030 | substance, product |
| 11753301 | February 2030 | substance, product |
| 12304813 | February 2030 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.